Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
NCT06186570

Efficacy of an Online-Based Self-Help Intervention for Auditory Hallucinations in Persons With Psychotic Disorders

Led by Charite University, Berlin, Germany · Updated on 2024-06-14

86

Participants Needed

1

Research Sites

78 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The proposed clinical trial aims to examine the efficacy of an online-based self-help intervention for auditory hallucinations in persons with psychotic disorders. The intervention is primarily based on Metacognitive Training (MKT) and Mindfulness-Based Group Therapy (MBGT). The investigators will utilize a mixed-method study design within a randomized controlled trial. The intervention group will be compared with a waitlist-control group (WL-TAU). Both study conditions are allowed to continue standard scheduled treatment. The aim is to analyze the efficacy of and the subjective satisfaction with the intervention, based on self-report assessments evaluated from baseline (T0) to post-intervention after 6 weeks (T1).

CONDITIONS

Official Title

Efficacy of an Online-Based Self-Help Intervention for Auditory Hallucinations in Persons With Psychotic Disorders

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Current experience of auditory hallucinations at least once a week
  • Diagnosis of a schizophrenia-spectrum disorder (DSM-5 or ICD-10 code F2x.x) or confirmed by Mini-International Neuropsychiatric Interview
  • Stable psychiatric medication for at least one month (minor dosage changes allowed)
  • Ability to give informed consent
  • Willingness and ability to participate in the self-help intervention
  • Access to a mobile device and internet
Not Eligible

You will not qualify if you...

  • Neurological disorders affecting cognitive function or severe traumatic brain injury
  • Acute suicidality at screening
  • Auditory hallucinations due to other primary diagnoses such as PTSD or borderline personality disorder
  • Acute substance abuse except nicotine and prescribed medication
  • Current electroconvulsive therapy
  • Current inpatient or day-care treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin

Berlin, Germany, 12203

Actively Recruiting

Loading map...

Research Team

K

Kerem Böge, PD Dr. Dr.

CONTACT

L

Laura Fässler, M.Sc.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here